Related Experiment Video

Updated: Jul 21, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.5K

Updates in the Management of Coronary Artery Disease: A Review Article

Archit Bansal1, Kishore Hiwale1

  • 1Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

Cureus
|January 17, 2024
PubMed

Insights

Coronary artery disease (CAD) management is advancing with new diagnostics, drugs, and procedures. A patient-centric approach combining lifestyle changes and cardiac rehabilitation improves outcomes for cardiovascular health.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Medical Research

Background:

  • Coronary artery disease (CAD) presents a global health challenge due to artery narrowing and blockage.
  • CAD complications include heart attacks and heart failure, impacting individuals and healthcare systems.
  • Advancements in understanding and managing CAD are driven by collaborative research and clinical efforts.

Purpose of the Study:

  • To review innovative treatments and recent trends in clinical practices for managing coronary artery disease.
  • To explore novel diagnostic technologies, pharmaceutical breakthroughs, and precision medicine in CAD care.
  • To examine advances in invasive procedures, lifestyle modifications, and cardiac rehabilitation for improved patient outcomes.

Main Methods:

  • Literature review of recent advancements in CAD diagnostics and therapeutics.
  • Analysis of novel medications targeting platelet disorders, lipid reduction, and angina.
  • Evaluation of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) techniques.
  • Assessment of the role of lifestyle changes and cardiac rehabilitation programs.

Main Results:

  • Novel diagnostic tools enhance early detection and risk stratification for CAD.
  • New medications and precision medicine offer tailored treatment strategies.
  • Innovations in PCI and CABG have improved revascularization and long-term outcomes.
  • Lifestyle interventions and cardiac rehabilitation are crucial for patient recovery and quality of life.

Conclusions:

  • Current CAD management integrates advanced diagnostics, pharmaceuticals, interventional procedures, and lifestyle interventions.
  • A patient-centric approach, incorporating multidisciplinary care, is essential for reducing CAD's impact.
  • Ongoing research continues to drive progress in developing innovative treatments and care models for cardiovascular health.

Keywords:
advancementscoronary artery diseasemanagementtherapiestreatment

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.0K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.9K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...